Production (Stage)
Proto Script Pharmaceutical Corp.
PSCR
$0.0003
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Revenue | 605.00K | 566.80K | 584.00K | 788.90K | 902.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 605.00K | 566.80K | 584.00K | 788.90K | 902.30K |
| Cost of Revenue | 253.10K | 254.30K | 226.60K | 224.40K | 150.10K |
| Gross Profit | 351.80K | 312.40K | 357.20K | 564.40K | 752.10K |
| SG&A Expenses | 1.32M | 1.20M | 1.07M | 862.60K | 741.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.58M | 1.45M | 1.29M | 1.09M | 891.10K |
| Operating Income | -971.00K | -885.40K | -709.00K | -298.20K | 11.10K |
| Income Before Tax | -8.39M | -8.10M | -7.84M | -7.18M | 12.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.39 | -8.10 | -7.84 | -7.18 | 0.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.39M | -8.10M | -7.84M | -7.18M | 12.60K |
| EBIT | -971.00K | -885.40K | -709.00K | -298.20K | 11.10K |
| EBITDA | -962.60K | -878.30K | -702.90K | -292.90K | 28.80K |
| EPS Basic | -0.04 | -0.03 | -0.03 | -0.02 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.04 | -0.03 | -0.03 | -0.02 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 583.20M | 864.54M | 852.48M | 1.00B | 967.55M |
| Average Diluted Shares Outstanding | 583.20M | 864.54M | 852.48M | 1.00B | 967.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |